Poster 11
- Kelley Tangredi
- Jun 8, 2024
- 1 min read
Updated: Jun 27, 2024
Pooled efficacy, Patient-Reported Outcomes, and Safety of Roflumilast Cream 0.15% From the INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials of Adults and Children With Atopic Dermatitis
Authors: Eric L. Simpson, Mark Boguniewicz, Lawrence F. Eichenfield, Mercedes E. Gonzales, Adelaide A. Hebert, Vimal H. Prajapati, Melinda Gooderham, David Krupa, David H. Chu, Robert C. Higham, David R. Berk
Poster 11